US FDA stumbles wound reputation as pivotal review of vaccine nears

- At a time when the FDA needs the public’s trust more than ever, the agency has been dragged into the political fray in a series of compounding incidents
- The drug regulator is preparing to review a Covid-19 vaccine that’s both pivotal for Trump’s re-election and is likely to be one of the most scrutinized and debated medical decisions in the agency’s history